for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Evonik to make lipids for BioNTech COVID-19 vaccine

ZURICH, Feb 11 (Reuters) - German specialty chemicals maker Evonik said on Thursday it is investing in the short-term expansion of production of lipids to be used to in BioNTech and Pfizer’s COVID-19 vaccine.

“We are ... doing everything possible to supply our partners with the critical lipids they need,” Christian Kullmann, chairman of Evonik’s executive board, said in a statement. (Reporting by John Miller; editing by Thomas Seythal)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up